Cite
A new potential oncogenic mutation in the FERM domain of JAK2 in BCR/ABL1-negative and V617F-negative chronic myeloproliferative neoplasms revealed by a comprehensive screening of 17 tyrosine kinase coding genes
MLA
Cristina Ormazábal, et al. “A New Potential Oncogenic Mutation in the FERM Domain of JAK2 in BCR/ABL1-Negative and V617F-Negative Chronic Myeloproliferative Neoplasms Revealed by a Comprehensive Screening of 17 Tyrosine Kinase Coding Genes.” Cancer Genetics and Cytogenetics, vol. 199, May 2010, pp. 1–8. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....24ca5177f9a851b09a27bb79929d4f7d&authtype=sso&custid=ns315887.
APA
Cristina Ormazábal, Paula Aranaz, C. Hurtado, María José Calasanz, M. García-Delgado, I. Erquiaga, José L. Vizmanos, & Francisco J. Novo. (2010). A new potential oncogenic mutation in the FERM domain of JAK2 in BCR/ABL1-negative and V617F-negative chronic myeloproliferative neoplasms revealed by a comprehensive screening of 17 tyrosine kinase coding genes. Cancer Genetics and Cytogenetics, 199, 1–8.
Chicago
Cristina Ormazábal, Paula Aranaz, C. Hurtado, María José Calasanz, M. García-Delgado, I. Erquiaga, José L. Vizmanos, and Francisco J. Novo. 2010. “A New Potential Oncogenic Mutation in the FERM Domain of JAK2 in BCR/ABL1-Negative and V617F-Negative Chronic Myeloproliferative Neoplasms Revealed by a Comprehensive Screening of 17 Tyrosine Kinase Coding Genes.” Cancer Genetics and Cytogenetics 199 (May): 1–8. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....24ca5177f9a851b09a27bb79929d4f7d&authtype=sso&custid=ns315887.